The list compiled by Alantra, an international financial services company, ranks companies according to their revenue growth over the past two years.

Richmond Pharmacology is delighted with the recognition and features in the lists top twenty at number 17. The Alantra Pharma Fast 50 is in its fifth year and was launched to recognise and celebrate successful business within the UK life sciences market.

The list includes analysis of businesses grouped into four distinct sub-sectors – Technology; Analytics, insights and communication; Pharma outsourcing; and Develop, wholesale and supply.

Richmond Pharmacology is categorised in the publication as a Contract research organisation providing services from design to delivery of early phase clinical trials.

Read the report in full

Latest news

Regulatory Pathways to Success

January 9, 2026
Structured pathways to accelerate development and approval.
Read more

Events

Clinical Trials Innovation Programme

10 - 11 February 2026
Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.
View event